These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 34389210

  • 1. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.
    Zhang XX, Wei M, Xiang R, Lu YM, Zhang L, Li YD, Zhang JH, Xing Q, Tu-Erhong ZK, Tang BP, Zhou XH.
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1741-1755. PubMed ID: 34389210
    [Abstract] [Full Text] [Related]

  • 2. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
    Alnaimat S, Doyle M, Krishnan K, Biederman RWW.
    Heart Rhythm; 2023 Nov; 20(11):1491-1501. PubMed ID: 37506990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis.
    Safiriyu I, Mehta A, Adefuye M, Nagraj S, Kharawala A, Hajra A, Shamaki GR, Kokkinidis DG, Bob-Manuel T.
    Am J Cardiol; 2023 Dec 15; 209():203-211. PubMed ID: 37863117
    [Abstract] [Full Text] [Related]

  • 5. Tricuspid regurgitation associated with implantable electrical device insertion: A systematic review and meta-analysis.
    Tatum R, Maynes EJ, Wood CT, Deb AK, Austin MA, O'Malley TJ, Choi JH, Massey HT, Morris RJ, Pavri BB, Tchantchaleishvili V.
    Pacing Clin Electrophysiol; 2021 Aug 15; 44(8):1297-1302. PubMed ID: 34081789
    [Abstract] [Full Text] [Related]

  • 6. Features of Lead-Induced Tricuspid Regurgitation in Patients With Heart Failure Events After Cardiac Implantation of Electronic Devices　- A Three-Dimensional Echocardiographic Study.
    Nakajima H, Seo Y, Ishizu T, Iida N, Sato K, Yamamoto M, Machino-Ohtsuka T, Nogami A, Ohte N, Ieda M.
    Circ J; 2020 Nov 25; 84(12):2302-2311. PubMed ID: 33071243
    [Abstract] [Full Text] [Related]

  • 7. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC, Friedman SE, Kono AT, Greenberg ML, Palac RT.
    Pacing Clin Electrophysiol; 2015 Nov 25; 38(11):1267-74. PubMed ID: 26234305
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U, Auger D, Thijssen J, Wolterbeek R, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA.
    Heart; 2014 Jun 25; 100(12):960-8. PubMed ID: 24449717
    [Abstract] [Full Text] [Related]

  • 10. Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.
    Wiechecka K, Wiechecki B, Kapłon-Cieślicka A, Tymińska A, Budnik M, Hołowaty D, Jakubowski K, Michalak M, Świętoń E, Stolarz P, Steckiewicz R, Grabowski M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G.
    Cardiol J; 2020 Jun 25; 27(6):797-806. PubMed ID: 31225634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads.
    Najib MQ, Vittala SS, Challa S, Raizada A, Tondato FJ, Lee HR, Chaliki HP.
    Tex Heart Inst J; 2013 Jun 25; 40(5):529-33. PubMed ID: 24391312
    [Abstract] [Full Text] [Related]

  • 13. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
    Murphy SP, Lew J, Yucel E, Singh J, Mela T.
    J Cardiovasc Electrophysiol; 2024 May 25; 35(5):1017-1025. PubMed ID: 38501386
    [Abstract] [Full Text] [Related]

  • 14. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation.
    Eleid MF, Blauwet LA, Cha YM, Connolly HM, Brady PA, Dearani JA, Espinosa RE.
    J Am Coll Cardiol; 2012 Feb 28; 59(9):813-8. PubMed ID: 22361401
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P, Özer N, Ateş AH, Yorgun H, Oto A, Aytemir K.
    Cardiol J; 2015 Feb 28; 22(6):637-44. PubMed ID: 26412607
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tricuspid valve incompetence following implantation of ventricular leads.
    Baquero GA, Luck J, Naccarelli GV, Gonzalez MD, Banchs JE.
    Curr Heart Fail Rep; 2015 Apr 28; 12(2):150-7. PubMed ID: 25488281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.